Lakefront Biotherapeutics (LKFT) EBT Margin Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 42,389.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,389.00 |
| Dec 31, 2025 | -7,855.00 |
| Sep 30, 2025 | -62,891.00 |
| Jun 30, 2025 | 33,430.00 |
| Mar 31, 2025 | -24,529.00 |
| Dec 31, 2024 | 20,355.00 |
| Sep 30, 2024 | -2,614.00 |
| Jun 30, 2024 | -7,171.00 |
| Mar 31, 2024 | 5,616.00 |
| Dec 31, 2023 | -305.00 |
| Sep 30, 2023 | 12,644.00 |
| Jun 30, 2023 | 34,129.00 |
| Mar 31, 2023 | 6,097.00 |
| Dec 31, 2022 | -3,683.00 |
| Sep 30, 2022 | 273,065.00 |
| Jun 30, 2022 | -31,731.00 |
| Mar 31, 2022 | -8,038.00 |
| Dec 31, 2021 | 3,549.00 |
| Sep 30, 2021 | -282,823.00 |
| Jun 30, 2021 | 7,062.00 |